Pharmaceutical group

Lafedar

4 medicines1 country

A group of 3 companies with 4 medicines in 1 country.

Its medicines

Group structure

3 companies in 2 countries

Argentina2

Ecuador1

Lafedar S.A.Authorisation holder

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine of every company in the group, current ones first.

4 medicines

Medicine	Substance	Country	Status
COLISTYN160 mg / 4 ml · Solución para inhalar	Colistin	Argentina	unknown
GEMFI - LIP900 mg · Comprimido recubierto	Gemfibrozil	Argentina	unknown
GLUMET1000 mg \| 850 mg · Comprimido recubierto	Metformin	Argentina	unknown
TOFLAM300 mg/ 100 ml - 100 mg/ 100 ml · Suspensión oftálmica estéril	Tobramicina dexametasona	Argentina	unknown

Sources and licences

Country	Medicines	Current	Past	Companies
Argentina	4	0	4	Companies All medicines

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

Ministerio de Salud / ANMAT

Ministerio de Salud / ANMAT, historical VNM changes, Actualizaciones del Vademecun Nacional de Medicamentos (VNM) - julio 2018, https://datos.salud.gob.ar/dataset/vademecun-nacional-de-medicamentos-vnm, CC BY 4.0, acquired 2026-10-09; structured factual adaptation.

Licence: Creative Commons Attribution

Ministerio de Salud / ANMAT

Ministerio de Salud / ANMAT, historical VNM changes, Actualizaciones del Vademecun Nacional de Medicamentos (VNM) - diciembre 2018, https://datos.salud.gob.ar/dataset/vademecun-nacional-de-medicamentos-vnm, CC BY 4.0, acquired 2026-10-09; structured factual adaptation.

Licence: Creative Commons Attribution

Anvisa, Brazil

Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.

Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions

Agencia Nacional de Regulación, Control y Vigilancia Sanitaria (ARCSA), Ecuador

Agencia Nacional de Regulación, Control y Vigilancia Sanitaria (ARCSA), caducados report, acquired 2026-10-29T19:40:11.852118+00:00

Licence: commercial redistribution permission not established

Agencia Nacional de Regulación, Control y Vigilancia Sanitaria (ARCSA), Ecuador

Agencia Nacional de Regulación, Control y Vigilancia Sanitaria (ARCSA), suspendidos_cancelados report, acquired 2026-10-29T19:40:39.796625+00:00

Licence: commercial redistribution permission not established

Agencia Nacional de Regulación, Control y Vigilancia Sanitaria (ARCSA), Ecuador

Agencia Nacional de Regulación, Control y Vigilancia Sanitaria (ARCSA), vigentes report, acquired 2026-10-29T19:39:28.336494+00:00

Licence: commercial redistribution permission not established

Report an error or request removal Corrections from the company itself are welcome.

Lafedar

Group structure

Argentina2

Ecuador1

Medicines

Know your medicines, with the sources.

Lafedar

Group structure

Argentina2

Ecuador1

Medicines

Know your medicines, with the sources.

Countries

Top substances

Sources and licences

At a glance

Work with Prognia

Other big groups

Group structure

🇦🇷Argentina2

🇪🇨Ecuador1

Medicines

Know your medicines, with the sources.

Group structure

🇦🇷Argentina2

🇪🇨Ecuador1

Medicines

Know your medicines, with the sources.

Countries

Top substances

Sources and licences

At a glance

Work with Prognia

Argentina2

Ecuador1

Argentina2

Ecuador1